A higher education programme to promote knowledge sharing and research innovation in health economics between leading British and Chinese experts and institutions.
The UK China Health and Economy Partnership is:
- funded by GlaxoSmithKline (GSK)
- project managed by Bournemouth University
- supported by the British Council and the Chinese Ministry of Education.
Aims
The UK China Health and Economy Partnership looks to set up long term collaborations between health economists in China and the UK to pursue transformative improvements in the infrastructure of healthcare systems. It seeks pioneering solutions to national and global health management challenges.
Priority disciplines
With Health economics as the primary field, activity also covers specialist topics such as:
- the health economics of oncology
- international best practice in Health Technology Assessments (HTAs)
- health policy.
Activity includes:
- workshops and masterclasses in specific pharmacoeconomics topics
- joint research projects and publications
- staff and student exchanges between UK and China.
Partner universities
China:
- Fudan University
- Shandong University
- Zhejiang University
UK:
- Bournemouth University
- University of Leeds
- University of Sheffield
- University of York
Highlights and progress
- The UK China Health and Economy Partnership was initiated in 2017 for a period of three years
- A series of visits between UK and China partner institutions is made regularly to share pharmeconomics approaches and to discuss partnership objectives
- A series of health economics workshops between UK and Chinese partner universities are planned [insert dates when known].
